A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.
about
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemiaPrognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.Role of FDG PET/CT in Diagnostic Evaluation of Granulocytic Sarcomas: A Series of 12 Patients.MPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect.6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells.Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients.The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia.Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia.The pretransplant systemic metabolic profile reflects a risk of acute graft versus host disease after allogeneic stem cell transplantation.High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.Prognostic impact of MYH9 expression on patients with acute myeloid leukemia.Targeting of cell metabolism in human acute myeloid leukemia--more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling?Fighting against hematological malignancy in China: from unique system to global impact.High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia.Synergistic cell death in FLT3-ITD positive acute myeloid leukemia by combined treatment with metformin and 6-benzylthioinosine.Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential.Cell intrinsic and extrinsic regulation of leukemia cell metabolism.Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity.Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot study.Metabonomics reveals metabolite changes in biliary atresia infants.High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia.Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia.Pharmacometabolomics identifies dodecanamide and leukotriene B4 dimethylamide as a predictor of chemosensitivity for patients with acute myeloid leukemia treated with cytarabine and anthracycline.MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis.Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism.Novel non-neutral mitochondrial DNA mutations found in childhood acute lymphoblastic leukemia.Reduced expression of NR4A1 activates glycolytic pathway in acute promyelocytic leukemia cells.High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.Metabolic Fingerprinting on a Plasmonic Gold Chip for Mass Spectrometry Based in Vitro Diagnostics.Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia.CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis.VEGF signaling in acute leukemia: mitochondrial connections.Serum NMR metabolomics to differentiate haematologic malignancies.Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicineThe Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for ThoughtAnalysis of the Metabolic Characteristics of Serum Samples in Patients With Multiple MyelomaClonal Heterogeneity Reflected by PI3K-AKT-mTOR Signaling in Human Acute Myeloid Leukemia Cells and Its Association with Adverse PrognosisSignalling mechanisms that regulate metabolic profile and autophagy of acute myeloid leukaemia cells
P2860
Q30276873-CB712E5B-5740-4FA1-B7D4-47FEDCFC4F25Q30847181-2053428A-C240-4AE1-A6CF-7D9FF08DDCABQ33827749-0DE559DE-22B7-4378-A719-2D1F57348FDDQ33866466-B92F1809-3B5D-4EFB-AF36-6E152FFD9EC8Q35749994-1FCB761C-8DBC-46BE-9668-C83F95B00A86Q35806875-B47D8193-58C6-4874-BC87-DD847B79544EQ36379644-B5D716A1-8824-4C0E-B844-105F620E2326Q37349113-CC52A49E-D57F-4096-887A-61AC8C156A78Q37366244-FAE37B03-8BD2-4CD0-89C5-2A4A1E16EE52Q37510247-C90B955B-31D6-4141-9CB5-A392228A07D5Q37702129-DBBD48D2-32D6-47E5-9278-89B8DA669EAFQ38606849-EE84B5CA-E2EB-405A-983B-CC5C0E91BC10Q38632968-E9AF9A53-DAFE-43BF-907B-E41BB902013AQ38697273-0A8C0600-FA51-4822-970A-D6F21E6412ABQ38736840-F2743343-B0CF-45E5-9029-E14C9DDA1919Q38740919-15E24D2F-7AC1-43EE-A2F8-607C8F56A550Q38742000-E8073199-DB10-44ED-A848-D4CE511ECEEEQ39070560-FA350925-1195-4048-8A95-E962D2006B00Q39989686-C014C824-D23F-4F59-A889-1033090D2566Q41300611-C8DB2F22-A47E-4D42-97C5-43F8A281F4D0Q41670609-DE4899AA-AFB1-4D38-B162-56B7DC1CF83AQ42378226-F37371C4-2A31-41EF-8502-F8B991DB527AQ46769583-0B9F7EB5-80CA-4B30-8956-DF22D522F3EBQ47100861-CF4A44EE-BF8E-4331-9A32-5B8AE0993FEEQ48043104-2D189272-2182-46B4-9F7F-95FDB9B78A9BQ48057726-7AB316C5-CBAB-45DA-8642-969FE8C26D38Q48174492-08ADE5FD-08F1-45A9-8631-2765D0773E80Q50061766-C78A9DF9-BFA5-4421-B19D-8272DE9AB045Q51103239-3A19C784-ED65-487B-8B45-891483F01FD1Q51417509-AB131CDA-633C-415A-8839-45E6B6F69B30Q51818965-47B2CB4A-EC01-4C92-8A99-7FA9150F7DF9Q52608845-38530D5F-F148-469A-AB84-D2825803B4A0Q53154264-A12BC2D4-0D7C-4991-A13D-30FD4A834DBEQ54965419-C568165A-F679-436A-BD17-EEFD4CFA7293Q55102185-C240CE02-6FC7-4FE0-88F5-9D2A2525DBE7Q57461758-7400F98F-59D3-4021-9171-D3214B67AF57Q57491369-09E90AC9-7ACF-4853-B0FE-8B28C4F64177Q58719351-C3841AB1-000A-4323-9327-F82B504A0508Q58739036-4EF89BE4-E142-4C84-86A8-5E4D4A49519BQ58767624-AF12292C-96BC-4164-A2C4-824F52A1EA3A
P2860
A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.
@en
type
label
A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.
@en
prefLabel
A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.
@en
P2093
P2860
P921
P1433
P1476
A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value
@en
P2093
Ai-Hua Zhao
Bing-Shun Wang
Jian-Qing Mi
Jian-Yong Li
Jin-Song Yan
Jing-Han Wang
Jun-Min Li
P2860
P304
P356
10.1182/BLOOD-2014-02-554204
P407
P50
P577
2014-07-08T00:00:00Z